Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials -

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Information type: Other primary research
Source: Diabetes Care
Specialities: Diabetes
Summary
This study (n=1,440) found that time in range (TIR, 3.9-10mmol/L) correlated with reduced incidence of microvascular complications (development of retinopathy and microalbuminuria increased by 64% and 40% for each 10% lower TIR, p<0.001 for each)
UKMi comment

Authors state that time in range of blood glucose may be an acceptable end point for clinical trials
Related links: